17
Nov 2020
Immune-boosting drug therapy gives years of extra life to thousands of Britons with incurable bladder cancer
According to a newly published landmark trial, patients whose cancer has spread to other areas live around a third longer on the medicine than those given standard chemotherapy treatment, some patients surviving over three years after the start of their treatment, more than double the average prognosis. Bladder cancer, which is diagnosed in over 10,000…